Positron Corporation Secures Multi-Unit Sale of PET-CT Scanners to Leading Cardiology Group
Positron Corporation (OTC: POSC) has secured a significant sale of four PET-CT 64-slice scanners to a leading nuclear cardiology group. The company's next-generation imaging systems feature a 72 cm wide-bore gantry, high-sensitivity detectors with reduced radiation exposure, and the smallest footprint in its class.
The PET-CT scanners deliver high-resolution anatomic and functional imaging for both cardiac and oncology applications, offering enhanced diagnostic capabilities from myocardial perfusion to tumor detection. The deal highlights growing market acceptance of Positron's advanced imaging technology and comprehensive support services.
Positron Corporation (OTC: POSC) ha concluso la vendita di rilievo di quattro scanner PET-CT a 64 strati a un importante gruppo di cardiologia nucleare. I sistemi di imaging di nuova generazione dell'azienda presentano un gantry a larga apertura da 72 cm, rivelatori ad alta sensibilit脿 che riducono l'esposizione alle radiazioni e l'ingombro pi霉 contenuto della loro categoria.
Gli scanner PET-CT offrono immagini anatomiche e funzionali ad alta risoluzione per applicazioni cardiache e oncologiche, potenziando le capacit脿 diagnostiche dalla perfusione miocardica all'individuazione dei tumori. L'accordo evidenzia la crescente accettazione sul mercato della tecnologia di imaging avanzata di Positron e dei suoi servizi di supporto completi.
Positron Corporation (OTC: POSC) ha asegurado la venta significativa de cuatro esc谩neres PET-TC de 64 cortes a un destacado grupo de cardiolog铆a nuclear. Los sistemas de imagen de nueva generaci贸n de la compa帽铆a cuentan con un gantry de amplia apertura de 72 cm, detectores de alta sensibilidad que reducen la exposici贸n a la radiaci贸n y la huella m谩s peque帽a de su categor铆a.
Los esc谩neres PET-TC proporcionan im谩genes anat贸micas y funcionales de alta resoluci贸n para aplicaciones cardiacas y oncol贸gicas, mejorando las capacidades diagn贸sticas desde la perfusi贸n mioc谩rdica hasta la detecci贸n de tumores. El acuerdo pone de relieve la creciente aceptaci贸n en el mercado de la tecnolog铆a de imagen avanzada de Positron y sus servicios de soporte integrales.
Positron Corporation (OTC: POSC)電� 靹犽弰鞝侅澑 頃奠嫭 鞁灔頃� 攴鸽９鞐� 64-鞀澕鞚挫姢 PET-CT 鞀れ簮雱� 4雽�毳� 韺愲Г頃橂姅 欷戩殧頃� 瓿勳暯鞚� 觳搓舶頄堨姷雼堧嫟. 須岇偓鞚� 彀劯雽� 鞓侅儊 鞁滌姢韰滌潃 歆侁步 72cm鞚� 鞕�鞚措摐 氤挫柎(gantry), 氚╈偓靹� 雲胳稖鞚� 欷勳澊電� 瓿犼皭霃� 瓴�於滉赴, 霃欔笁鞐愳劀 臧�鞛� 鞛戩潃 靹れ箻 氅挫爜鞚� 韸轨鞙茧 頃╇媹雼�.
鞚� PET-CT 鞀れ簮雱堧姅 鞁灔 氚� 膦呾枒 攵勳暭 氇憪鞐� 雽�頃� 頃措秬頃欖爜路旮半姤鞝� 瓿犿暣靸侂弰 鞓侅儊鞚� 鞝滉车頃橂┌, 鞁芳 甏�毳� 瓴�靷秬韯� 膦呾枒 韮愳鞐� 鞚措ゴ旮瓣箤歆� 歆勲嫧 靹彪姤鞚� 頄レ儊鞁滍偟雼堧嫟. 鞚措矆 瓿勳暯鞚� Positron鞚� 觳嫧 鞓侅儊 旮办垹瓿� 韽磩鞝� 歆�鞗� 靹滊箘鞀り皜 鞁滌灔鞐愳劀 鞝愳爯 雿� 氚涭晞霌れ棳歆�瓿� 鞛堨潓鞚� 氤挫棳欷嶋媹雼�.
Positron Corporation (OTC: POSC) a conclu la vente importante de quatre scanners PET-CT 64 coupes 脿 un groupe de cardiologie nucl茅aire de premier plan. Les syst猫mes d'imagerie de nouvelle g茅n茅ration de la soci茅t茅 disposent d'un gantry 脿 large ouverture de 72 cm, de d茅tecteurs 脿 haute sensibilit茅 r茅duisant l'exposition aux radiations et de l'encombrement le plus faible de leur cat茅gorie.
Les scanners PET-CT fournissent des images anatomiques et fonctionnelles 脿 haute r茅solution pour des applications cardiaques et oncologiques, offrant des capacit茅s diagnostiques accrues, de la perfusion myocardique 脿 la d茅tection des tumeurs. Cet accord met en 茅vidence l'acceptation croissante sur le march茅 de la technologie d'imagerie avanc茅e de Positron et de ses services d'assistance complets.
Positron Corporation (OTC: POSC) hat den bedeutenden Verkauf von vier PET-CT-Scannern mit 64 Schichten an eine f眉hrende Nuklearkardiologie-Gruppe abgeschlossen. Die bildgebenden Systeme der n盲chsten Generation des Unternehmens verf眉gen 眉ber eine 72 cm breite Gantry, hochempfindliche Detektoren mit verringerter Strahlenbelastung und die kleinste Stellfl盲che ihrer Klasse.
Die PET-CT-Scanner liefern hochaufl枚sende anatomische und funktionelle Bilder f眉r kardiologische und onkologische Anwendungen und bieten erweiterte diagnostische M枚glichkeiten von der Myokardperfusion bis zur Tumorerkennung. Der Vertrag unterstreicht die wachsende Marktakzeptanz von Positrons fortschrittlicher Bildgebungstechnologie und umfassenden Supportleistungen.
- Secured major multi-unit sale of 4 PET-CT scanners to nationally recognized cardiology group
- Product offers dual-use capabilities for both cardiac and oncology applications
- Scanner features smallest and lightest design in its class, increasing installation flexibility
- System provides reduced radiation exposure through high-sensitivity detectors
- None.
Niagara Falls, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (鈥淧ositron鈥� or the 鈥淐ompany鈥�) (OTC: POSC), a leader in molecular imaging technology and services, today announced the sale of four (4) PET-CT 64-slice scanners to a nationally recognized nuclear cardiology group specializing in advanced cardiovascular diagnostics and interventional care.
This substantial multi-unit order underscores the growing demand for Positron鈥檚 next-generation PET-CT imaging solutions, which combine cutting-edge hardware with comprehensive clinical, technical, and training support. Positron鈥檚 PET-CT scanners are quickly becoming the preferred solution for practices seeking superior performance, value, and efficiency in cardiac PET imaging.
Engineered to optimize both clinical outcomes and operational efficiency, Positron鈥檚 PET-CT scanners deliver high-resolution anatomic and functional imaging for both cardiac and oncology applications. Key features include a 72 cm wide-bore gantry for enhanced patient comfort, high-sensitivity detectors that reduce radiation exposure, and a compact design, the smallest and lightest in its class, making it ideal for diverse clinical environments.
Positron鈥檚 advanced data acquisition capabilities deliver fast, high precision imaging, enhancing diagnostic confidence while expanding the range of studies physicians can perform, from myocardial perfusion to tumor detection and neurological assessments.
Adel Abdullah, President of Positron, commented, 鈥淲e are proud to partner with one of the nation鈥檚 most respected nuclear cardiology medical groups. This milestone reflects the growing recognition of Positron鈥檚 advanced PET imaging systems and full-service clinical support.鈥� Mr. Abdullah continued, 鈥淎t Positron, our mission is to transform cardiac PET imaging by delivering scalable, high-performance solutions that not only meet today鈥檚 clinical needs but also prepare healthcare providers for the future of precision diagnostics.鈥�
About Positron Corporation
Positron Corporation is a medical technology company that co-develops, manufactures, and sells state-of-the-art PET and PET-CT imaging systems and clinical services to nuclear medicine healthcare providers throughout North America.
Positron specializes in the field of cardiac Positron Emission Tomography (PET) imaging, the gold standard in cardiac diagnostics. Positron鈥檚 innovative PET/PET-CT technologies, clinical services and practice solutions enables healthcare providers to accurately diagnose coronary artery disease and improve patient outcomes while practicing cost effective medicine.
Positron's Attrius庐 PET and NeuSight PET-CT imaging systems and distinct market position are substantial advantages unique to Positron that will facilitate the adoption of cardiac PET and the growth of the nuclear imaging market. Positron will soon offer a state-of-the-art PET-CT 4D molecular imaging device in the Affinity PET-CT 4D 64-Slice. Positron鈥檚 PET-CT(s) will enable nuclear cardiologists to utilize the full capabilities of molecular imaging and nuclear medicine. Positron鈥檚 PET-CT systems will also enable the Company to fully service and meet the demands of the vast oncology imaging segment of nuclear medicine.聽
Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its co-developer, supplier, and R&D venture with Shenyang Intelligent Neuclear Technology Co. a subsidiary of Neusoft Medical Systems.聽聽
Please visit the Company鈥檚 website at:
Forward-Looking Statements聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽
This press release contains statements which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Positron Corporation, and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results even if new information becomes available in the future.
FOR FURTHER INFORMATION, please visit the company鈥檚 website at , or contact:
Investor Relations Contact:
Skyline Corporate Communications Group, LLC
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
FAQ
What is the significance of Positron Corporation's recent PET-CT scanner sale?
What are the key features of Positron's PET-CT scanners?
How does Positron's PET-CT technology benefit healthcare providers?
What support services does Positron Corporation offer with their PET-CT scanners?
What applications can Positron's PET-CT scanners be used for?
